Bernard Le Foll
Waypoint Centre for Mental Health Care · Centre for Addiction and Mental Health · The Centre for Addiction and Mental Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
25
all conditions, ClinicalTrials.gov
NIH grants tied to them
6
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name Bernard Le Foll as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:15 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07292883 · Accelerated dTMS Smoking CessationWaypoint Centre for Mental Health Care · recruiting · Tobacco Use Disorder, Addiction Nicotine · principal investigator
- N/ANCT06595576 · Cannabis Edibles and Simulated DrivingCentre for Addiction and Mental Health · completed · Cannabis, Driving Under the Influence · principal investigator
- Ph4NCT05729243 · Cytisine for Smoking CessationCentre for Addiction and Mental Health · completed · Tobacco Use Disorder, Alcohol Use Disorder, Smoking Cessation · principal investigator
- N/ANCT05334914 · ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming IndividualsCentre for Addiction and Mental Health · unknown · Methamphetamine Abuse, Methamphetamine-dependence · principal investigator
- Ph2NCT04801641 · A Pilot Trial of Nabilone for the Treatment of ObesityCentre for Addiction and Mental Health · terminated · Obesity · principal investigator
- Ph2NCT04139668 · Vivitrol Treatment for Cannabis Use DisorderCentre for Addiction and Mental Health · terminated · Cannabis Use Disorder · principal investigator
- N/ANCT04083144 · Deep rTMS and Varenicline for Smoking CessationCentre for Addiction and Mental Health · completed · Tobacco Use Disorder, Smoking Cessation · principal investigator
- Ph1/Ph2NCT03813602 · Detection of Cannabis Impairment With an Eye TrackerCentre for Addiction and Mental Health · completed · Cannabis Intoxication · principal investigator
- N/ANCT03037060 · Exploring Regulation and Function of Dopamine D3 Receptors in Alcohol Use Disorders: A [11C]-(+)-PHNO StudyCentre for Addiction and Mental Health · completed · Alcohol Use Disorder · principal investigator
- N/ANCT02921282 · Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic PolymorphismsCentre for Addiction and Mental Health · completed · Cigarette Smoking Behavior · principal investigator
- N/ANCT02710578 · Alcohol Effects on Driving-related Skills of Young DriversCentre for Addiction and Mental Health · completed · Psychomotor Impairment · principal investigator
- N/ANCT02514720 · Nicotine Metabolizers and [11C]-(+)-PHNOCentre for Addiction and Mental Health · completed · Nicotine Dependence · principal investigator
- Ph1NCT01999530 · The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot StudyCentre for Addiction and Mental Health · completed · Healthy · principal investigator
- Ph2NCT01876810 · Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco AddictionCentre for Addiction and Mental Health · completed · Nicotine Dependence · principal investigator
- N/ANCT01748799 · Fixed or Self-Titrated Dosages of Sativex on Cannabis UsersCentre for Addiction and Mental Health · completed · Cannabis Dependence · principal investigator
- Ph2NCT01747850 · Sativex and Behavioral-relapse Prevention Strategy in Cannabis DependenceCentre for Addiction and Mental Health · completed · Cannabis Dependence · principal investigator
- Ph1/Ph2NCT01699828 · Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PETCentre for Addiction and Mental Health · completed · Smoking Cessation, Tobacco Use Cessation · principal investigator
- Ph2NCT01642433 · Prazosin for Smoking CessationCentre for Addiction and Mental Health · terminated · Nicotine Dependence · principal investigator
- Ph4NCT01638377 · Pharmacotherapy for Alcohol Dependence in Convicted Drinking DriversCentre for Addiction and Mental Health · terminated · Alcohol Dependence · principal investigator
- Ph1NCT01638364 · Dopamine Release in the Human Brain Following Alcohol AdministrationCentre for Addiction and Mental Health · completed · Heavy Drinking · principal investigator
- N/ANCT01632189 · The Effect of Varenicline on D2/D3 Receptor Binding in SmokersCentre for Addiction and Mental Health · completed · Nicotine Dependence · principal investigator
- N/ANCT01592409 · Cannabis Effects on Driving-related Skills of Young DriversCentre for Addiction and Mental Health · completed · Psychomotor Impairment · principal investigator
- N/ANCT01302262 · Smoking-induced Dopamine Release: a [11C]-(+)-PHNO PET Study in HumansCentre for Addiction and Mental Health · completed · Tobacco Use Disorder · principal investigator
- Ph2NCT01228994 · Baclofen for Smoking Cessation in a Non-Psychiatric PopulationCentre for Addiction and Mental Health · terminated · Nicotine Dependence · principal investigator
- N/ANCT00390923 · Testing a Full Substitution Therapy Approach As Treatment of Tobacco DependenceCentre for Addiction and Mental Health · terminated · Nicotine Dependence · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Role of Histamine H3 Receptors on Alcohol ResponsesR21AA026035 · NIAAA · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2018 to 2019 · $141,497 awarded in 2019Same name and institution; not confirmed by an ID
- Exploring regulation and function of Dopamine D3 Receptors in Alcohol Use Disorders. A [11C]-(+)-PHNO PET studyR21AA023967 · NIAAA · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2016 to 2017 · $140,484 awarded in 2017Same name and institution; not confirmed by an ID
- Incubation of craving in human smokers: a [11C]- (+)-PHNO studyR21DA042325 · NIDA · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2016 to 2017 · $156,710 awarded in 2017Same name and institution; not confirmed by an ID
- Impact of nicotine metabolism on brain dopamine transmissionR21DA039453 · NIDA · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2015 to 2016 · $146,054 awarded in 2016Same name and institution; not confirmed by an ID
- Sativex associated with behavioural-relapse prevention strategy as treatment for cannabis dependenceR21DA031906 · NIDA · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2011 to 2016 · $39,960 awarded in 2016Grant number is on one of their registry trials
- Exploring occupancy of dopamine D3 receptor by buspirone in humans using positronR21DA033515 · NIDA · CENTRE FOR ADDICTION AND MENTAL HEALTH · fiscal years 2012 to 2013 · $132,274 awarded in 2013Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.